| Sunnyside Presbyterian Retirement Community | |
| 3935 Sunnyside Drive, Suite A, Harrisonburg, Virginia 22801 | |
| (540) 568-8200 | |
| Name | Sunnyside Presbyterian Retirement Community |
|---|---|
| Location | 3935 Sunnyside Drive, Suite A, Harrisonburg, Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 84 |
| Occupancy Rate | 88.69% |
| Medicare ID (CCN) | 495387 |
| Legal Business Name | Sunnyside Presbyterian Home |
| Ownership Type | Non Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Muscle Flex Inc. announced today that it is ready to go for a Monday, December 7 National commercial release for its Beagle StepFit Pedometer.
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
The research teams headed by Prof. Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) and Prof. Marko Salmi (University of Turku and the National Institute for Health and Welfare) have discovered that the SHARPIN protein regulates human cell activity.
The success of antiretroviral therapy for HIV/AIDS "has fooled us into believing HIV is under control. It is not. … The fact remains that no sexually acquired infection has ever been controlled in democratic societies except by vaccines," Lawrence Corey, president and director of the Fred Hutchinson Cancer Research Center and principal investigator of the international HIV Vaccine Trials Network, writes in a Wall Street Journal opinion piece.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17.24 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.42 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 51.16 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.34 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 5.22 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 1.15 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 8.75 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.92 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.6 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.68 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.57 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 27.5 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 9.62 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.06 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 70.87 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 83.76 | 82.93 |
News Archive
Muscle Flex Inc. announced today that it is ready to go for a Monday, December 7 National commercial release for its Beagle StepFit Pedometer.
Taro Pharmaceutical Industries Ltd. announced that it has been granted an Investigational New Drug ("IND") exemption by the United States Food and Drug Administration, ("FDA"), to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid), one of a class of non-sedating barbiturate compounds currently in development by the Company.
The research teams headed by Prof. Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) and Prof. Marko Salmi (University of Turku and the National Institute for Health and Welfare) have discovered that the SHARPIN protein regulates human cell activity.
The success of antiretroviral therapy for HIV/AIDS "has fooled us into believing HIV is under control. It is not. … The fact remains that no sexually acquired infection has ever been controlled in democratic societies except by vaccines," Lawrence Corey, president and director of the Fred Hutchinson Cancer Research Center and principal investigator of the international HIV Vaccine Trials Network, writes in a Wall Street Journal opinion piece.
› Verified 3 days ago
Harrisonburg Hlth & Rehab Cntr Location: 1225 Reservoir Street, Harrisonburg, Virginia 22801 Phone: (540) 433-2623 | |
Accordius Health At Harrisonburg Llc Location: 94 South Avenue, Harrisonburg, Virginia 22801 Phone: (540) 433-2791 | |
Vmrc, Complete Living Care Location: 1475 Virginia Avenue, Harrisonburg, Virginia 22802 Phone: (540) 564-3500 | |
Sunnyside Presbyterian Retirement Community Location: 3935 Sunnyside Drive, Suite A, Harrisonburg, Virginia 22801 Phone: (540) 568-8200 |